NASDAQ:ASND

Ascendis Pharma A/s Stock Insider Trading

Healthcare > Biotechnology

Buy ASND

*Your capital is at risk

$216.79

+0.190 (+0.0877%)

At Close: Jun 03, 2026

Ascendis Pharma A/S Stock Insider Power

Based on the 87 latest insides trades, we have calculated the insider power to be positive at 81.34. In total, the insiders bought 1.6M and sold 19.46K ASND shares in the last 87 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 87 transactions)	81.34
● Buy	1.6M shares
● Sell	19.46K shares
99% Buy Activity Moderate Positive Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 02, 2026 Buy	Ordinary Shares P-Purchase	Smith Scott Thomas EVP & Chief Financial Officer	C-Suite Officer	100 Value: $21.9K
May 29, 2026 Buy	Ordinary Shares P-Purchase	Smith Scott Thomas EVP & Chief Financial Officer	C-Suite Officer	250 Value: $55.8K
May 29, 2026 Buy	Ordinary Shares P-Purchase	Bienaime Jean Jacques Director	Director	200 Value: $44.8K
May 29, 2026 Buy	Ordinary Shares P-Purchase	Bienaime Jean Jacques Director	Director	200 Value: $44.5K
May 29, 2026 Buy	Ordinary Shares P-Purchase	Bienaime Jean Jacques Director	Director	100 Value: $22.4K
May 26, 2026 Buy	Ordinary Shares P-Purchase	Bienaime Jean Jacques Director	Director	200 Value: $47.2K
May 26, 2026 Buy	Ordinary Shares P-Purchase	Bienaime Jean Jacques Director	Director	200 Value: $47.9K
May 11, 2026 Sell	Ordinary Shares S-Sale	Jensen Flemming Steen See Remarks	Officer	19 460 Value: $4.64M
Mar 23, 2026 Buy	Warrants	Bienaime Jean Jacques Director	Director	9 160 Value: $1.58M
Mar 23, 2026 Buy	Ordinary Shares	Bienaime Jean Jacques Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Smith Scott Thomas EVP & Chief Financial Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	Warrants	Smith Scott Thomas EVP & Chief Financial Officer	C-Suite Officer	14 504 Value: $2.03M
Mar 18, 2026 Buy	Restricted Stock Units	Smith Scott Thomas EVP & Chief Financial Officer	C-Suite Officer	9 552 Value: $2.17M
Mar 18, 2026 Buy	Warrants	Jensen Michael Wolff EVP, Chief Legal Officer	Officer	30 000 Value: $1.87M
Mar 18, 2026 Buy	Warrants	Jensen Michael Wolff EVP, Chief Legal Officer	Officer	27 000 Value: $2.92M
Mar 18, 2026 Buy	Warrants	Jensen Michael Wolff EVP, Chief Legal Officer	Officer	22 755 Value: $4.01M
Mar 18, 2026 Buy	Warrants	Jensen Michael Wolff EVP, Chief Legal Officer	Officer	14 504 Value: $2.03M
Mar 18, 2026 Buy	Restricted Stock Units	Jensen Michael Wolff EVP, Chief Legal Officer	Officer	9 552 Value: $2.17M
Mar 18, 2026 Buy	Warrants	Bodenhoff Mads SVP & Pao	Officer	30 000 Value: $3.74M
Mar 18, 2026 Buy	Warrants	Bodenhoff Mads SVP & Pao	Officer	3 117 Value: $435.3K
Mar 18, 2026 Buy	Warrants	Bodenhoff Mads SVP & Pao	Officer	3 687 Value: $405.6K
Mar 18, 2026 Buy	Restricted Stock Units	Bodenhoff Mads SVP & Pao	Officer	2 768 Value: $629.5K
Mar 18, 2026 Buy	Ordinary Shares	Pedersen Anni Lotte Kirstine Sonderbjerg EVP & Chief Admin Officer	Officer	0 Value: $0
Mar 18, 2026 Buy	Warrants	Pedersen Anni Lotte Kirstine Sonderbjerg EVP & Chief Admin Officer	Officer	20 000 Value: $743.6K
Mar 18, 2026 Buy	Warrants	Pedersen Anni Lotte Kirstine Sonderbjerg EVP & Chief Admin Officer	Officer	45 000 Value: $2.80M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ASCENDIS PHARMA A/S

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra...

Read Full Profile Here